Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This is an exploratory clinical study to presume the optimum usage and dosage for a
therapeutic confirmatory study by evaluating the efficacy and safety of Avanafil 50mg, 100mg,
200mg or placebo administered orally in patients with erectile dysfunction. In conclusions,
Patients with erectile dysfunction (ED) were administered placebo, Avanafil 50mg, 100mg or
200mg 30 minutes before sexual intercourse for 8 weeks.